Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine plus radiotherapy for local breast cancer recurrence after mastectomy
2005-005734-12Phase 4Completed
- Sponsor
- GEICAM
- Start
- Feb 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of capecitabine in breast cancer, sponsored by GEICAM. Primary endpoint: Complete clinical response rate. Started Feb 2007; status: completed.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-005734-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005734-12.